April 5, 2019

Multicenter Clinical Study of Long-Term Brivaracetam Use Finds Brivaracetam Effective and Well-Tolerated in Patients with Drug-Resistant Epilepsy

Researchers assessed long-term effectiveness and tolerability of brivaracetam in patients with focal epilepsy. According to this multicenter retrospective study, brivaracetam was effective and well-tolerated in a large population of patients with predominantly drug-resistant epilepsy. There were no unexpected adverse events (AEs) over 1 year. The most frequently reported AEs were somnolence, irritability and dizziness.

Related News

February 14, 2024

Fintepla Safely Reduces Seizures in Children Younger than 2, Study Finds

Treatment with Fintepla (fenfluramine) appeared to be reasonably safe and lower seizure frequency in five children with Dravet syndrome who started on the therapy before they were two years old.

December 14, 2023

The Mozart Effect Myth: Listening to Music Does Not Help Against Epilepsy

“Mozart’s music is beautiful, but unfortunately, we cannot expect relief from epilepsy symptoms from it”, conclude the researchers.

November 20, 2023

How Yoga May Help Reduce Epilepsy Seizures, Anxiety

“Our study showed that doing yoga can alleviate the burden of epilepsy and improve the overall quality of life by reducing this perceived stigma.”